e.

ECOLOGICAL ASPECTS

1. **Environmental Impact Assessment (EIA):**

- Pfizer conducts thorough EIAs for all new and expanded operations. An EIA is a process that

evaluates the potential environmental impacts of a proposed project or development. It includes

assessing the effects on air quality, water resources, biodiversity, and the overall ecosystem.

- Example: Before establishing a new manufacturing facility, Pfizer assesses the potential impact

on local ecosystems, air quality, and water sources to ensure that the project aligns with

environmental regulations and sustainable practices.

2. **Waste Management:**

- Pfizer has a comprehensive waste management program to minimize its environmental

footprint. This includes efforts to reduce, recycle, and responsibly dispose of waste.

- Example: Pfizer may implement recycling programs for materials commonly used in its

operations, such as paper, plastics, and packaging materials. The company might also explore

partnerships with local recycling facilities to ensure proper waste disposal.

3. **Water Conservation:**

- Pfizer recognizes the importance of water conservation and has implemented measures to

reduce water consumption.

- Example: The company may employ rainwater harvesting systems to collect and use rainwater

for non-potable purposes, such as irrigation or cooling. Recycling wastewater from manufacturing

processes is another example, where treated water can be reused within the facility, reducing the

demand on freshwater resources.

4. **Energy Efficiency:**

- Pfizer is committed to improving energy efficiency and decreasing greenhouse gas emissions

associated with its operations.

- Example: The company may invest in energy-efficient equipment, such as LED lighting or high-

efficiency machinery. Additionally, Pfizer might incorporate renewable energy sources like solar
panels or wind turbines to power its facilities, thereby reducing reliance on non-renewable

energy.

5. **Sustainable Packaging:**

- Pfizer is dedicated to using sustainable packaging materials and reducing overall packaging

waste.

- Example: The company may explore alternatives to traditional packaging materials, such as

biodegradable or recyclable materials. Reducing the size and weight of packaging without

compromising product safety is another strategy to minimize environmental impact.

f. OTHER EXTERNAL FACTORS THAT MAY BE MORE DIRECTLY RELEVANT TO YOUR BUSINESS

Economic conditions: The economic conditions in the Philippines, such as GDP growth, inflation

rates, and employment levels, can impact Pfizer's business. During periods of economic growth,

there may be increased healthcare spending and a higher demand for pharmaceutical products.

On the other hand, during economic downturns, there may be a decrease in healthcare budgets

and a more cautious approach to spending on medications.

Healthcare system: The structure and effectiveness of the healthcare system in the Philippines

are crucial for Pfizer's operations. Factors such as accessibility, affordability, and quality of

healthcare services can influence the demand for Pfizer's products. For example, if the healthcare

system is well-funded and efficient, it may lead to increased access to healthcare and a higher

demand for Pfizer's medications.

Competition: The pharmaceutical industry in the Philippines is highly competitive, with both local

and international companies compete for market share. Pfizer needs to consider the strategies

and offerings of its competitors, such as pricing, product portfolio, distribution networks, and

marketing efforts. Staying ahead of the competition and continuously innovating is essential for

Pfizer's success.

Government policies: Government policies and regulations play a significant role in Pfizer's

business. Policies related to drug registration, pricing, intellectual property rights, and healthcare
reimbursement can directly impact Pfizer's operations and profitability. For example, changes in

drug pricing regulations may affect the pricing strategy of Pfizer's products in the Philippines. 5.

Public opinion: Public opinion and perception of pharmaceutical companies, including Pfizer, can

influence their reputation and brand image. Factors such as trust, transparency, and ethical

practices play a role in shaping public opinion. Pfizer needs to engage with the public, healthcare

professionals, and patient advocacy groups to ensure a positive perception and maintain trust.

Social and cultural factors: Social and cultural factors, such as beliefs, attitudes, and healthcare

practices, can impact Pfizer's business. Understanding the local culture, traditions, and healthcare

preferences is crucial for developing effective marketing strategies and tailoring products to meet

the needs of the Filipino population. For example, cultural beliefs about healthcare and

treatment options may influence the acceptance and adoption of Pfizer's medications. These

external factors require Pfizer to closely monitor and adapt to changes in the business

environment to remain competitive and meet the evolving needs of the market.

KPI (Key Performance Indicator)

Sales growth: Sales growth is a crucial KPI for Pfizer as it measures the increase in revenue over a

specific period. Pfizer may track the sales growth of its pharmaceutical products in the Philippines

to assess the effectiveness of its marketing and sales strategies. For example, Pfizer may set a

target of achieving a certain percentage of sales growth annually.

Market share: Market share is a KPI that measures Pfizer's portion of the total pharmaceutical

market in the Philippines. Pfizer may monitor its market share to evaluate its competitiveness

and track its performance compared to competitors. Increasing market share indicates a stronger

presence in the market and a higher demand for Pfizer's products.

Product launches: Product launches are an essential KPI for Pfizer as it represents the

introduction of new pharmaceutical products to the market. Pfizer may track the number of

successful product launches and the market acceptance of these products. The KPI can help

assess Pfizer's ability to innovate and meet the healthcare needs of the Filipino population.

Clinical trials: Clinical trials are a critical part of Pfizer's research and development process. Pfizer

may track the progress and success rate of clinical trials conducted in the Philippines. This KPI
helps Pfizer evaluate the effectiveness and safety of its investigational drugs and assess their

potential for regulatory approval and commercialization.

Patient access: Patient access is a KPI that measures the availability and affordability of Pfizer's

medications to the Filipino population. Pfizer may track the number of patients who have access

to its medicines, especially for critical diseases or conditions. Improving patient access ensures

that Pfizer's products reach those who need them most.

Employee satisfaction: Employee satisfaction is an important KPI for Pfizer as it reflects the

engagement and well-being of its workforce. Pfizer may measure employee satisfaction through

surveys, feedback, and retention rates. A satisfied and motivated workforce contributes to

enhanced productivity, innovation, and overall business success.

Customer satisfaction: Customer satisfaction is a KPI that measures the satisfaction levels of

healthcare professionals, patients, and other stakeholders who interact with Pfizer. Pfizer may

collect feedback, conduct surveys, and analyze customer satisfaction ratings. High customer

satisfaction indicates that Pfizer's products and services meet the needs and expectations of its

customers.

SWOT OF THE COMPANY

 Strong brand recognition and reputation: Pfizer is globally recognized as a leading

pharmaceutical company, known for its high-quality products and commitment to safety.

 Global research and development capabilities: Pfizer has extensive research and

development capabilities, enabling the company to innovate and develop new drugs and

treatments.

 Broad portfolio of products and vaccines: Pfizer offers a diverse range of pharmaceutical

products and vaccines, catering to various therapeutic areas and patient needs.

 Commitment to quality and safety: Pfizer prioritizes quality and safety in its products,

adhering to stringent regulatory standards and ensuring patient well-being.

 Presence in over 100 countries: Pfizer's wide global presence allows the company to reach a

large customer base and expand its market reach.

 Strong sales and distribution network in the Philippines: Pfizer has established a robust sales
 and distribution network in the Philippines, enabling efficient delivery of its products to

healthcare providers and patients.

Weaknesses:

 High prices for some products: Pfizer's pricing strategy may result in higher costs for certain

medications, which could impact affordability and access for some patients.

 Dependence on a few key products: Pfizer's revenue is reliant on a few key products, which

poses a risk if there are challenges or competition in those specific therapeutic areas.

 Lawsuits and regulatory challenges: Pfizer may face legal and regulatory challenges, such as

patent disputes or product liability lawsuits, which can impact its reputation and financial

performance.

 Exposure to currency fluctuations: As a global company, Pfizer is exposed to currency

fluctuations, which can affect its revenue and profitability in different markets.

 Competition from other pharmaceutical companies: Pfizer faces competition from both

domestic and international pharmaceutical companies, requiring continuous innovation and

effective marketing strategies.

Opportunities:

 Growing demand for healthcare in the Philippines: The increasing demand for healthcare

services in the Philippines presents an opportunity for Pfizer to expand its market and reach

more patients.

 Expanding access to healthcare through government programs: Government initiatives

aimed at improving healthcare access and affordability can create opportunities for Pfizer to

provide its products to a wider population.

 Increasing prevalence of chronic diseases: The rising incidence of chronic diseases in the

Philippines opens avenues for Pfizer to develop and offer treatments for these conditions.

 Growing demand for personalized medicine: The increasing focus on personalized medicine

presents opportunities for Pfizer to develop targeted therapies and precision medicine

solutions.

 Development of new technologies and treatments: Advancements in technology and

medical research provide opportunities for Pfizer to develop innovative treatments and

therapies.
Threats:

 Economic recession: Economic downturns can impact healthcare spending and affordability,

potentially affecting Pfizer's sales and revenue.

 Changes in government policies: Changes in government policies, regulations, or pricing

controls can impact Pfizer's operations and profitability.

 Competition from generic and biosimilar drugs: The availability of generic and biosimilar

drugs poses a threat to Pfizer's market share and pricing power. - Counterfeit drugs: The

presence of counterfeit drugs in the market can negatively impact Pfizer's brand reputation

and patient safety.

 Public health crises: Outbreaks of public health crises, such as pandemics or epidemics, can

disrupt healthcare systems and impact Pfizer's operations.

INTERNAL STRATEGIC ISSUES

1. Reliance on a few key products: Pfizer's revenue in the Philippines may be heavily dependent

on a few key products. This reliance poses a risk if there are challenges or competition in those

specific therapeutic areas. Pfizer needs to diversify its product portfolio to reduce the impact of

potential fluctuations in demand or the introduction of competing products.

Example: If Pfizer's revenue in the Philippines is primarily driven by a single blockbuster drug, any

patent expiration or generic competition for that drug could significantly impact Pfizer's sales and

profitability in the country.

2. High costs: Pfizer's research and development (R&D) costs are high, and the company's

products are often priced higher than generic or biosimilar alternatives. This pricing strategy can

pose challenges in terms of affordability and access for patients, particularly in a market where

cost-consciousness is prevalent.

Example: If Pfizer's products are priced significantly higher than similar medications in the

Philippines, it may face difficulties in gaining market share and may face criticism for the

perceived high costs of its products.

3. Regulatory challenges: Pfizer must navigate and comply with various laws and regulations in
the Philippines. This includes drug registration, pricing regulations, intellectual property rights,

and compliance with local healthcare and safety standards. Regulatory changes or challenges can

impact Pfizer's ability to bring new products to market or maintain existing products.

Example: If the Philippine government introduces stricter regulations on drug pricing or imposes

additional requirements for drug registration, Pfizer may need to adjust its pricing strategy or

invest more resources in regulatory compliance.

4. Employee turnover: Pfizer may face challenges in retaining and attracting qualified employees

in the Philippines. Competition for talent in the pharmaceutical industry can be intense, and

Pfizer needs to ensure that it offers competitive compensation, career development

opportunities, and a positive work environment to retain skilled employees. Example: If Pfizer

experiences high employee turnover in the Philippines, it may face difficulties in maintaining

continuity, knowledge transfer, and productivity, which can impact its overall performance and

operations.

5. Brand awareness: Pfizer's brand awareness in the Philippines may not be as high as it is in

other countries. Building and enhancing brand awareness is crucial for Pfizer to establish trust,

credibility, and preference among healthcare professionals and patients. Example: If Pfizer's

brand awareness in the Philippines is relatively low, it may face challenges in gaining market

share and competing against pharmaceutical companies with stronger brand recognition.

Effective marketing and promotional strategies are necessary to increase awareness and visibility

of Pfizer's products and values.

ORGANIZATIONAL ELEMENTS

Core functions:

1.Research and development: Pfizer's research and development (R&D) function focuses on

discovering and developing new drugs, vaccines, and therapies. R&D teams conduct scientific

research, preclinical and clinical trials, and regulatory submissions to bring innovative products to

market.
 - Example: Pfizer's R&D team in the Philippines may collaborate with global R&D

centers to conduct clinical trials for new medications and contribute to the

development of breakthrough treatments.

2. Manufacturing: Pfizer's manufacturing function involves the production and packaging of

pharmaceutical products. This includes ensuring compliance with quality standards, maintaining

efficient production processes, and managing the supply of raw materials and finished products.

- Example: Pfizer's manufacturing facilities in the Philippines may produce a range of medications,

vaccines, and other pharmaceutical products, ensuring high-quality standards and timely delivery

to meet market demand.

3. Marketing and sales: Pfizer's marketing and sales function focuses on promoting and

distributing its products to healthcare professionals, hospitals, pharmacies, and patients. This

includes developing marketing strategies, conducting market research, and building relationships

with key stakeholders.

Example: Pfizer's marketing and sales teams in the Philippines may collaborate with healthcare

professionals to educate them about Pfizer's products, organize medical conferences, and

implement marketing campaigns to raise awareness and drive product sales.

4. Supply chain management: Pfizer's supply chain management function involves managing the

flow of materials, products, and information from suppliers to customers. This includes

procurement, logistics, inventory management, and distribution.

- Example: Pfizer's supply chain management team in the Philippines may work closely with

suppliers, distributors, and logistics partners to ensure the timely and efficient delivery of

pharmaceutical products to healthcare providers and patients.

5. Finance: Pfizer's finance function handles financial planning, budgeting, accounting, and

reporting. This includes managing financial resources, ensuring compliance with financial

regulations, and providing financial analysis and insights to support decision-making.

- Example: Pfizer's finance team in the Philippines may oversee budgeting and financial

forecasting, track sales and revenue, manage expenses, and ensure compliance with local

financial regulations.
Support functions:

1. Human resources: Pfizer's human resources function is responsible for talent acquisition,

employee development, performance management, and ensuring a positive work environment.

Example: Pfizer's human resources team in the Philippines may recruit and onboard new

employees, provide training and development opportunities, manage employee benefits, and

foster a culture of diversity and inclusion.

2. Information technology: Pfizer's information technology function supports the organization's

technology infrastructure, systems, and digital capabilities. This includes managing IT systems,

data security, software development, and providing technical support. Example: Pfizer's IT team

in the Philippines may ensure the smooth operation of computer systems, network

infrastructure, and software applications, as well as support digital initiatives and data privacy

compliance.

3. Legal and regulatory: Pfizer's legal and regulatory function ensures compliance with laws,

regulations, and intellectual property rights. This includes managing legal contracts, handling

regulatory submissions, and protecting Pfizer's intellectual property. Example: Pfizer's legal and

regulatory team in the Philippines may provide legal advice, review contracts, ensure compliance

with local regulations, and protect Pfizer's patents and trademarks.

4. Quality assurance: Pfizer's quality assurance function focuses on maintaining and improving

product quality, ensuring compliance with regulatory standards, and implementing quality

control processes. Example: Pfizer's quality assurance team in the Philippines may conduct

quality audits, monitor manufacturing processes, review product documentation, and ensure

adherence to Good Manufacturing Practices (GMP) and other quality standards.

5. Corporate social responsibility: Pfizer's corporate social responsibility (CSR) function involves

initiatives aimed at making a positive impact on society and the environment. This includes

philanthropy, community engagement, and sustainability efforts. Example: Pfizer's CSR team in

the Philippines may collaborate with local organizations, support healthcare programs, promote

health education, and implement sustainability initiatives to contribute to the well-being of the

community and the environment.

1. Investment in research and development: Pfizer's investment in research and development

(R&D) plays a crucial role in driving productivity and growth. By allocating resources to R&D,

Pfizer can develop new and innovative medicines and vaccines to address unmet medical needs

and improve patient outcomes. Example: Pfizer's investment in R&D in the Philippines may

involve collaborations with local research institutions, clinical trials for new medications, and the

development of innovative treatment options for prevalent diseases in the country.

2. Expansion of manufacturing capacity: Pfizer's expansion of manufacturing capacity in the

Philippines contributes to productivity and growth. By increasing production capabilities, Pfizer

can meet the growing demand for its products and ensure a reliable supply to healthcare

providers and patients. Example: Pfizer's expansion of manufacturing capacity in the Philippines

may involve the construction of new manufacturing facilities, the adoption of advanced

production technologies, and the hiring and training of additional manufacturing personnel.

3. Launch of new products: Pfizer's launch of new products in the Philippines drives productivity

and growth by expanding its product portfolio and capturing new market opportunities.

Introducing innovative medications and vaccines allows Pfizer to address evolving healthcare

needs and gain a competitive edge. Example: Pfizer's launch of new products in the Philippines

may include breakthrough therapies for chronic diseases, novel vaccines for infectious diseases,

or targeted treatments for specific patient populations.

4. Strengthening of sales and distribution network: Pfizer's efforts to strengthen its sales and

distribution network in the Philippines contribute to productivity and growth. By enhancing its

reach and accessibility, Pfizer can effectively promote and distribute its products to healthcare

providers and patients. Example: Pfizer's strengthening of the sales and distribution network in

the Philippines may involve expanding its sales force, establishing partnerships with local

distributors, and implementing targeted marketing strategies to increase awareness and

product uptake.